Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours.
Jens Otto Lunde JørgensenWouter W de HerderWendy A MartinTeodora KolarovaMuriël MarksCecilia FollinWanda GeilvoetShlomo MelmedPublished in: Advances in therapy (2023)
The results identified key features of injection devices for SRL therapy which merit consideration for optimal management and underscore the importance of patient partnership in treatment decisions.
Keyphrases